Theator Nabs $15.5M to Scale AI-Driven Surgical Intelligence Platform What You Should Know: – Theator raises $15.5M in Series A funding to support the company’s mission of using AI and computer vision to eradicate disparity and variability in surgical care. – The startup plans to use this round to scale its commercial operations and partnerships with U.S. providers, grow its R&D team and cement its status as a world-leading provider of AI-powered Surgical Intelligence solutions. Theator, a Palto Alto, CA-based Surgical Intelligence platform leveraging AI and computer vision to improve surgeon performance, today announced that it has raised $15.5M in an oversubscribed Series A round led by Insight Partners, joined by new investor Blumberg Capital, and supported by all existing investors including NFX, StageOne Ventures, KdT Ventures, and iAngels. Several notable individual investors, including 23andMe’s Co-founder and CEO Anne Wojcicki, former Netflix Chief Product Officer Neil Hunt, and Zebra Medical Vision’s Co-founder Eyal Gura, also participated in the round. The latest round of funding brings Theator to a total of $18.5 million raised to date.